GlassScriptPhysician profile
Maher C Nahlawi
NPI 1881688596
$14,221.78
in general payments reported to CMS, 2019-2025
51 companies · $1,801 in 2025
The $1,801 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,295 · 2020: $2,498 · 2021: $1,902 · 2022: $2,207 · 2023: $1,811 · 2024: $1,708 · 2025: $1,801.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,320.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,702.97 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $1,284.86 | 2019-2025 | |
| Pfizer INC. | $1,264.61 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $1,213.74 | 2019-2024 | Xarelto, Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $978.28 | 2019-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $786.92 | 2019-2025 | Lifevest |
| Amgen INC. | $765.64 | 2019-2025 | Repatha, Repatha |
| Medtronic Vascular, INC. | $702.60 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $524.67 | 2019-2025 | Wainua, Farxiga, Lokelma |
| Abiomed | $522.37 | 2019-2025 | Impella |
| Amarin Pharma, INC. | $504.55 | 2019-2022 | |
| Boston Scientific Corporation | $399.50 | 2019-2024 | Watchman Access System |
| Alnylam Pharmaceuticals INC. | $355.30 | 2022-2025 | Onpattro |
| Merck Sharp & Dohme LLC | $288.32 | 2022-2025 | Verquvo |
| Novo Nordisk INC | $283.91 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $226.39 | 2024-2025 | |
| W. L. Gore & Associates, INC. | $192.56 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $180.49 | 2021-2025 | |
| Arbor Pharmaceuticals, INC. | $152.58 | 2020-2021 | |
| Esperion Therapeutics, INC. | $147.95 | 2020-2024 | Nexletol |
| Shockwave Medical, INC | $140.05 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Scpharmaceuticals INC. | $136.28 | 2025 | |
| Lundbeck LLC | $119.74 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $112.99 | 2019-2023 | Livalo |
| Venclose INC. | $99.02 | 2020 | |
| Sanofi-Aventis U.S. LLC | $97.96 | 2019-2022 | |
| Inari Medical, INC. | $83.98 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Edwards Lifesciences Corporation | $82.14 | 2022-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Elutia, INC. | $81.05 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $80.71 | 2023-2024 | Inpefa |
| Bard Peripheral Vascular, INC. | $77.34 | 2021-2023 | Venclose Maven Catheter |
| Abbott Laboratories | $66.43 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $61.20 | 2024 | Arcalyst |
| Philips North America LLC | $52.67 | 2022-2023 | |
| Akcea Therapeutics, INC. | $45.09 | 2020 | |
| Medtronic, INC. | $43.35 | 2021-2023 | Venaseal |
| Astellas Pharma US INC | $43.07 | 2022-2023 | Lexiscan |
| Kiniksa Pharmaceuticals, LTD. | $31.65 | 2021-2023 | Arcalyst |
| Kestra Medical Technology Services, INC. | $30.64 | 2025 | Assure Wcd |
| Allergan, INC. | $30.20 | 2019 | |
| Azurity Pharmaceuticals, INC. | $29.76 | 2023 | Edarbi |
| Cardiva Medical, INC. | $26.06 | 2023 | Cardiva Vascade 6/7f Vcs |
| Corcept Therapeutics | $25.84 | 2025 | Korlym |
| Itamar Medical INC | $24.52 | 2025 | Watchpatone |
| Inspire Medical Systems, INC. | $22.79 | 2023 | Inspire |
| Daiichi Sankyo INC. | $19.29 | 2019 | |
| Bridgebio Pharma, INC. | $17.06 | 2025 | Attruby |
| Biotronik INC. | $17.06 | 2019 | |
| Glaxosmithkline, LLC. | $16.92 | 2025 | Arexvy, Shingrix |
| Tactile Systems Technology INC | $14.65 | 2022 | |
| Lilly USA, LLC | $14.06 | 2025 | Mounjaro, Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maher Nahlawi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.